Andrew J. Armanino - 14 Jun 2022 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Issuer symbol
BTTX on OTC
Transactions as of
14 Jun 2022
Net transactions value
+$20,846
Form type
4
Filing time
16 Jun 2022, 19:11:14 UTC
Previous filing
10 Jun 2022
Next filing
21 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $20,846 +15,000 $1.39 15,000 14 Jun 2022 By son F1
holding BTTX Common Stock 151,328 14 Jun 2022 By Armanino Trust F2
holding BTTX Common Stock 13,334 14 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3850 to $1.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.